DIVA Laboratories, Ltd. (TPEX:4153)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.55
+0.15 (0.49%)
Apr 29, 2026, 1:30 PM CST
-27.00%
Market Cap 1.78B
Revenue (ttm) 884.63M
Net Income (ttm) 90.43M
Shares Out 58.67M
EPS (ttm) n/a
PE Ratio 19.72
Forward PE n/a
Dividend 1.48 (4.76%)
Ex-Dividend Date Jun 13, 2025
Volume 8,070
Average Volume 58,800
Open 30.55
Previous Close 30.40
Day's Range 30.55 - 30.55
52-Week Range 30.05 - 43.95
Beta 0.30
RSI 26.12
Earnings Date May 5, 2026

About DIVA Laboratories

DIVA Laboratories, Ltd. engages in the development, manufacture, and sale of medical equipment and computer related devices worldwide. The company provides endo/surgical displays, a static and dynamic image for hybrid and integrated ORs applications; color and mono displays for radiology and medical imaging applications; touch displays/human machine interface products; medical and industrial cases; and displays to original design manufacturers (ODM) and original equipment manufacturers (OEMs) customers. It also offers emergency room/ operating ... [Read more]

Sector Healthcare
Founded 1995
Employees 154
Stock Exchange Taipei Exchange
Ticker Symbol 4153
Full Company Profile

Financial Performance

In 2025, DIVA Laboratories's revenue was 868.84 million, an increase of 0.76% compared to the previous year's 862.32 million. Earnings were 90.54 million, a decrease of -3.33%.

Financial Statements

News

There is no news available yet.